Novel therapeutic strategies by regulatory T cells in allergy

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Natural CD4+CD25+FoxP3+ regulatory T cells (Treg) actively suppress physiological and pathological responses, therefore playing a critical role in controlling peripheral tolerance to self antigens and maintaining immune homeostasis. In normal individuals, natural Treg and interleukin- 10-secreting Treg are able to suppress Th2 responses to allergens, whereas lower levels of Treg or defect in their functionality have been described as potential mechanisms for inducing allergic diseases. In animal models, adoptive transfer of CD4+CD25+Treg has been shown as a promising strategy for preventing or treating allergic disorders. Recent studies show that induction of Treg activity is associated with suppression of allergic responses in allergic patients treated with specific immunotherapy. Herein, I review the potential of Treg as exciting targets for developing new immunotherapeutic strategies for treating allergic diseases.

Original languageEnglish
Title of host publicationT Cell Regulation in Allergy, Asthma and Atopic Skin Diseases
Pages150-157
Number of pages8
Volume94
DOIs
Publication statusPublished - 2008
Externally publishedYes

Publication series

NameChemical Immunology and Allergy
Volume94
ISSN (Print)16602242

Fingerprint

Regulatory T-Lymphocytes
Hypersensitivity
Peripheral Tolerance
Adoptive Transfer
Autoantigens
Interleukin-10
Immunotherapy
Allergens
Homeostasis
Animal Models
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Medicine(all)

Cite this

Elkord, E. (2008). Novel therapeutic strategies by regulatory T cells in allergy. In T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases (Vol. 94, pp. 150-157). (Chemical Immunology and Allergy; Vol. 94). https://doi.org/10.1159/000154999

Novel therapeutic strategies by regulatory T cells in allergy. / Elkord, Eyad.

T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases. Vol. 94 2008. p. 150-157 (Chemical Immunology and Allergy; Vol. 94).

Research output: Chapter in Book/Report/Conference proceedingChapter

Elkord, E 2008, Novel therapeutic strategies by regulatory T cells in allergy. in T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases. vol. 94, Chemical Immunology and Allergy, vol. 94, pp. 150-157. https://doi.org/10.1159/000154999
Elkord E. Novel therapeutic strategies by regulatory T cells in allergy. In T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases. Vol. 94. 2008. p. 150-157. (Chemical Immunology and Allergy). https://doi.org/10.1159/000154999
Elkord, Eyad. / Novel therapeutic strategies by regulatory T cells in allergy. T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases. Vol. 94 2008. pp. 150-157 (Chemical Immunology and Allergy).
@inbook{dc00b2e424ea41b6b59470c7b9826ecd,
title = "Novel therapeutic strategies by regulatory T cells in allergy",
abstract = "Natural CD4+CD25+FoxP3+ regulatory T cells (Treg) actively suppress physiological and pathological responses, therefore playing a critical role in controlling peripheral tolerance to self antigens and maintaining immune homeostasis. In normal individuals, natural Treg and interleukin- 10-secreting Treg are able to suppress Th2 responses to allergens, whereas lower levels of Treg or defect in their functionality have been described as potential mechanisms for inducing allergic diseases. In animal models, adoptive transfer of CD4+CD25+Treg has been shown as a promising strategy for preventing or treating allergic disorders. Recent studies show that induction of Treg activity is associated with suppression of allergic responses in allergic patients treated with specific immunotherapy. Herein, I review the potential of Treg as exciting targets for developing new immunotherapeutic strategies for treating allergic diseases.",
author = "Eyad Elkord",
year = "2008",
doi = "10.1159/000154999",
language = "English",
isbn = "9783805586283",
volume = "94",
series = "Chemical Immunology and Allergy",
pages = "150--157",
booktitle = "T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases",

}

TY - CHAP

T1 - Novel therapeutic strategies by regulatory T cells in allergy

AU - Elkord, Eyad

PY - 2008

Y1 - 2008

N2 - Natural CD4+CD25+FoxP3+ regulatory T cells (Treg) actively suppress physiological and pathological responses, therefore playing a critical role in controlling peripheral tolerance to self antigens and maintaining immune homeostasis. In normal individuals, natural Treg and interleukin- 10-secreting Treg are able to suppress Th2 responses to allergens, whereas lower levels of Treg or defect in their functionality have been described as potential mechanisms for inducing allergic diseases. In animal models, adoptive transfer of CD4+CD25+Treg has been shown as a promising strategy for preventing or treating allergic disorders. Recent studies show that induction of Treg activity is associated with suppression of allergic responses in allergic patients treated with specific immunotherapy. Herein, I review the potential of Treg as exciting targets for developing new immunotherapeutic strategies for treating allergic diseases.

AB - Natural CD4+CD25+FoxP3+ regulatory T cells (Treg) actively suppress physiological and pathological responses, therefore playing a critical role in controlling peripheral tolerance to self antigens and maintaining immune homeostasis. In normal individuals, natural Treg and interleukin- 10-secreting Treg are able to suppress Th2 responses to allergens, whereas lower levels of Treg or defect in their functionality have been described as potential mechanisms for inducing allergic diseases. In animal models, adoptive transfer of CD4+CD25+Treg has been shown as a promising strategy for preventing or treating allergic disorders. Recent studies show that induction of Treg activity is associated with suppression of allergic responses in allergic patients treated with specific immunotherapy. Herein, I review the potential of Treg as exciting targets for developing new immunotherapeutic strategies for treating allergic diseases.

UR - http://www.scopus.com/inward/record.url?scp=52249121388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52249121388&partnerID=8YFLogxK

U2 - 10.1159/000154999

DO - 10.1159/000154999

M3 - Chapter

SN - 9783805586283

VL - 94

T3 - Chemical Immunology and Allergy

SP - 150

EP - 157

BT - T Cell Regulation in Allergy, Asthma and Atopic Skin Diseases

ER -